BiotechTube
Home/Endacea/Constance Neely Wilson, M.D.
CN

Constance Neely Wilson, M.D.

President, CEO, Chief Scientific Officer, Founder, Director

Endacea

Therapeutic Areas

OncologyCritical CareNephrology

Endacea Pipeline

DrugIndicationPhase
L-97-1Sepsis and Acute Renal FailurePreclinical
Mutant plasmid cDNA for A1ARCancerPreclinical